Abstract
Transcriptional activity of the vitamin D receptor (VDR) gene is regulated by androgen receptor (AR) gene and both are associated with renal stone formation. We examined gene polymorphisms of VDR (PCR-RFLP) and AR (GeneScan analysis) in 125 stone formers and 150 controls from north India. Genotype Ff of Fok-I and Tt of Taq-I demonstrated significantly higher risk (P<0.001, OR=3.559 and P=0.019, 1.830 respectively). Variant f allele exhibited 1.7-folds higher risk. Ff of Fok-I and Aa of Apa-I gene polymorphism showed higher risk in males only. Mean CAG repeat was significantly higher in hypercalciuric patients as compared to normocalciuric (mean=21.62 ± 3.384 vs. 20.11 ± 3.182; P=0.034). Combined effects 1.8-folds higher risk in patients with Tt genotype of Taq-I and short CAG repeat. Thus, association of FokI and TaqI VDR gene polymorphisms suggest VDR as an important genetic marker for urolithiasis. Further, patients with combination of Tt of Taq-I and short CAG repeat were at higher risk for stone formation.
Similar content being viewed by others
References
Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, et al. Association between vitamin D receptor gene Polymorphisms and fasting idiopathic Hypercalciuria in recurrent Stone-forming patients. Urol 2004; 64: 833–838.
Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K. A Polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol 2007; 177: 2361–2365.
Chen WC, Wu HC, Lin WC, Wu MC, Hsu CD, Tsai FJ. The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int 2001; 88: 432–436.
Aswegen CH, Hurter P, van der Merwe CA, du Plessis DJ. The relationship between total urinary testosterone and renal calculi. Urol Res 1989; 17: 181–183.
Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 1999; 20: 2131–2135.
Slattery ML, Murtaugh M, Caan B, Wolff R, Ma KN, Samowitz W. Association between dietary fats and VDR genotypes and colon and rectal cancers. Int J Cancer Prev 2004;1: 193–205.
Peehl DM, Feldman D. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer. J Steroid Biochem Mol Biol 2004; 92: 307–315.
Zamuda JM, Cauley JA, Ferrell RE. Molecular epidemiological of Vitamin D receptor variants. Epidemiol Rev 2000; 22: 203–217.
Bid HK, Mishra DK and Mittal RD. Vitamin-D Receptor (VDR) Gene (Fok-I, Taq-I & Apa-I) Polymorphisms in Healthy Individuals from North Indian Population. Asian Pac J Cancer Prev 2005; 6: 147–152.
Nagaba Y, Heishi M, Tazawa HY, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kid Dis 1998; 32: 464–469.
Goodman HO, Holmes RP, Assimos DG. Genetic factors in calcium oxalate stone disease. J Urol 1995; 153: 301–307.
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 20: 284–287.
Wieacker PF, Knoke I, Jakubiczka S. Clinical and molecularaspects of androgen receptor defects. Exp Clin Endocrinol Diabetes 1998; 106: 446–453.
Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12: 241–253.
Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994; 22: 3181–3186.
Mitsumori K, Terai A, Oka H, Segawa T, Ogura K, Yoshida O, Ogawa O. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 1999; 41: 253–257.
Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ. Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int 2001; 87: 168–171.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (Fok-1) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res 1997; 12: 1043–1048.
Riggs BL, Nguyen TV, Melton LJ 3rd, Morrison NA, O’Fallon WM, Kelly PJ, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995; 10: 991–996.
Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 1997; 337: 77–82.
Cram DS, Song B, McLachlan RI, Trounson AO. CAG trinucleotide repeats in the androgen receptor gene of infertile men exhibit stable inheritance in female offspring conceived after ICSI. Mol Hum Reprod 2000; 6: 861–966.
Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 1–12.
Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997; 12: 915–921.
Relan V, Khullar M, Singh SK, Sharma SK. Association of vitamin d receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India. Urol Res 2004; 32: 236–240.
Vezzoli G, Soldati L, Proverbio MC, Adamo D, Rubinacci A, Bianchi G, et al Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol 2002; 15: 158.
Bid HK, Chaudhary H, Mittal RD. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr Nephrol 2005a; 20: 773–776.
Nishijima S, Sugaya K, Naito A, Morozumi M, Hatano T, Ogawa Y. Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol 2002; 167: 2188.
Ozkaya O, Soylemezoglu O, Misirlioglu M, Gonen S, Buyan N, Hasanoglu E. Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur Urol 2003; 44:150.
Sezgin G, Bilen CY, Asci NKR, Bagci H, Yilmaz AF. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006; 34: 47–52.
Lee YH, Huang WC, Chiang H, Chen MT, Huang JK, Chang LS. Determination role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 1992; 147: 1134–1138.
Lee YH, Huang WC, Huang JK, Chang LS. Testosterone enhances whereas estrogen inhibit calcium oxalate stone formation in ethylene glycol treated rats. J Urol 1996; 156: 502–505.
Curhan GC. Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 1999; 13: 629–631.
Murthy S, Agoulnik IU, Weigel NL. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Prostate 2005; 64: 362–372.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mittal, R.D., Mishra, D.K., Srivastava, P. et al. Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis. Indian J Clin Biochem 25, 119–126 (2010). https://doi.org/10.1007/s12291-010-0023-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-010-0023-0